Healthcare - Biotechnology - NASDAQ - GB
$ 0.5866
-0.778 %
$ 150 M
Market Cap
-1.63
P/E
Price Target
Average
375.20%
Revenue Forecast
Estimate
42.87%
EBIT
Estimate
--16.14%
Net Income
Estimate
38.69%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Adaptimmune Therapeutics plc
Wall Street analysts predict an average 1-year price target for ADAP of $2.79 , with forecasts ranging from a low of $1 to a high of $4 .
ADAP Lowest Price Target
Wall Street Target
1 USD
70.47%
ADAP Average Price Target
Wall Street Target
2.79 USD
375.20%
ADAP Highest Price Target
Wall Street Target
4 USD
581.90%
REVENUE FORECAST
Revenue Forecast Chart ADAP
EBIT FORECAST
EBIT Forecast Chart ADAP
NET INCOME FORECAST
Net Income Chart ADAP